PanTher Therapeutics

Austin, TX · Founded 2014 · Privately Held (backing)

Developer of a cancer treatment technology designed to deliver therapeutics directly to the tumor site. PanTher Therapeutics is based in Austin, TX and was founded in 2014. Its last reported valuation was $10.9 million in Jun 2022. It has raised $15.5 million across 2 recorded rounds; the latest was a $3 million seed round in Mar 2025.

Last reported valuation
$10.9M
Oct 2026
Priced at
—
Total raised
$15.5M
Last round
Seed Round
Mar 2025
What is PanTher Therapeutics worth?
$10.9Mlast reported valuation · Oct 2026

PanTher Therapeutics's last reported valuation, Jun 2022. Nothing priced has surfaced since.

Free account
More of PanTher Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch PanTher Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

PanTher Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Mar 2025Seed Round$3.0M▮
Nov 2023Seed Round$2.7M▮
Unlock post-money valuations

Membership and data by Private Market View

PanTher Therapeutics valuation

PanTher Therapeutics's last reported valuation was $10.9 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has PanTher Therapeutics raised?

PanTher Therapeutics has raised $15.5 million in total; 2 of its rounds are on record. The largest on record was a $3 million seed round in Mar 2025.

PanTher Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Apr 2025 ($3 million sold to 26 investors).

How PanTher Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For PanTher Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about PanTher Therapeutics

What is PanTher Therapeutics worth?
PanTher Therapeutics is valued at $10.9M as of Oct 2026. PanTher Therapeutics's last reported valuation, Jun 2022. Nothing priced has surfaced since.
How much has PanTher Therapeutics raised?
PanTher Therapeutics has raised $15.5M in total funding across 2 recorded rounds.
When did PanTher Therapeutics last raise?
PanTher Therapeutics last raised in Mar 2025 (Seed Round), raising $3.0M.